CRY - CryoLife, Inc.

NYSE - NYSE Delayed price. Currency in USD
Currency in USD

Valuation measures

Market cap (intra-day) 5968.35M
Enterprise value 31.18B
Trailing P/E 586.82
Forward P/E 166.21
PEG ratio (5-yr expected) 13.10
Price/sales (ttm)3.53
Price/book (mrq)3.49
Enterprise value/revenue 34.29
Enterprise value/EBITDA 639.00

Trading information

Stock price history

Beta (5Y Monthly) 0.66
52-week change 3-6.16%
S&P500 52-week change 324.46%
52-week high 333.00
52-week low 320.76
50-day moving average 324.25
200-day moving average 326.95

Share statistics

Avg vol (3-month) 3207.73k
Avg vol (10-day) 3187.12k
Shares outstanding 537.5M
Float 35.96M
% held by insiders 13.82%
% held by institutions 172.14%
Shares short (29 Nov 2019) 4991.58k
Short ratio (29 Nov 2019) 44.8
Short % of float (29 Nov 2019) 43.26%
Short % of shares outstanding (29 Nov 2019) 42.64%
Shares short (prior month 31 Oct 2019) 4916.78k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.03
Trailing annual dividend yield 30.12%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 318 Dec 2015
Ex-dividend date 49 Dec 2015
Last split factor (new per old) 22/3
Last split date 328 Dec 2000

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2018
Most-recent quarter (mrq)30 Sep 2019

Profitability

Profit margin 0.59%
Operating margin (ttm)5.90%

Management effectiveness

Return on assets (ttm)1.74%
Return on equity (ttm)0.59%

Income statement

Revenue (ttm)274.32M
Revenue per share (ttm)7.42
Quarterly revenue growth (yoy)5.10%
Gross profit (ttm)175.78M
EBITDA 30.17M
Net income avi to common (ttm)1.61M
Diluted EPS (ttm)0.04
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)36.69M
Total cash per share (mrq)0.98
Total debt (mrq)245.03M
Total debt/equity (mrq)88.30
Current ratio (mrq)4.30
Book value per share (mrq)7.40

Cash flow statement

Operating cash flow (ttm)25.29M
Levered free cash flow (ttm)5.65M